*MEDCAP'S BUSINESS AREA SPECIALTY PHARMA ACQUIRES XGX PHARMA
*PURCHASE PRICE COMPRISES AN INITIAL CASH PAYMENT OF DKK 135 MILLION, POTENTIAL ADDITIONAL PAYMENT UP TO DKK 140 MILLION
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 25-JUN-202505:30:09.377 GMT